Skip to main content
Federal & State Lawfederalstatelaw.com
Home/Federal/Federal Register/2023-27304
Notice2023-27304

Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Establishment

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 13, 2023

Issuing agencies

Health and Human Services DepartmentFood and Drug Administration

Abstract

Under the Federal Advisory Committee Act, the Food and Drug Administration (FDA) is announcing the establishment of the Genetic Metabolic Diseases Advisory Committee. The Commissioner of Food and Drugs (Commissioner) has determined that it is in the public interest to establish such a committee. Duration of this committee is 2 years from the date the Charter is filed, unless the Commissioner formally determines that renewal is in the public interest.

View on FederalRegister.gov →Plain-text source
Indexed from Federal Register on December 13, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.